Up-regulation of major histocompatibility complex class I chain-related protein A expression in the malignant hematopoietic cell lines by interferon-α

( views:100, downloads:0 )
WU Hui(Department of Clinical Laboratory, Zibo Central Blood Station, Zibo 250000, China)
NIU Jia-feng()
Journal Title:
Journal of Leukemia & Lymphoma
Volume 20, Issue 12, 2011
Key Word:
Interferon-alpha;Genes, MHC cell Ⅰ;Killer cells, natural;MICA

Abstract: Objective To investigate the effect of interferon-α (IFN-α) on expression of major histocompatibility complex (MHC) class I chain-related protein A (MICA) in the malignant hematopoietic cell lines.Methods The myeloid leukemia cell lines K562 and B-cell lymphoma cell line Raji were treated with IFN-α.The expression of MICA was measured by RT-PCR and immunohistochemical staining at mRNA and protein level.The cytotoxicity of human NK cells to the IFN-α treated malignant hematopoietic cells was detected by MTT method.Results After being treated with 1000 U/ml IFN-α,up-regulation of MICA mRNA in Raji and K562 cells were respectively found in 24 h and 48 hours (t =17.016,P <0.05; t =5.616,P <0.05).After being treated with IFN-α 72 hours,up-regulation of MICA mRNA in K562 and Raji were found at the dose of 500 U/ml and 1000 U/ml dose (t =6.622,P <0.05; t =9.071,P <0.05).The mRNA and protein expression of MICA were up-regulated by IFN-o in the two malignant hematopoietic cells in a time and dosedependent manner.After being treated with 1000 U/ml IFN-o for 72 hours,the susceptibility of the two malignant hematopoietic cells to NK cytolysis was significantly increased (t =20.016,P <0.05; t =7.969,P <0.05).Moreover,the up-regulated susceptibility can be blocked by anti-MICA antibody.Conclusion IFN-α can up-regulate the MICA expression in the malignant hematopoietic cell lines and thereby enhance the susceptibility to cytolysis of NK cells.

  • [1]Allan NC,Shepherd PCA,Richards SM.UK medical research council randomized, multicentre trial of interferon-alpha n1 for chronic myeloid leukemia: improved survival intrespective of cytogenetic response.The UK medical research council's working parties for therapeutic trials in adult leukemia.Lancet,1995,345:1392-1397.
  • [2]孙自敏,刘欣,朱薇波,等.干扰素α-2b联合低剂量阿糖胞苷治疗慢性髓细胞白血病的临床研究.白血病·淋巴瘤,2004,13:23-25.
  • [3]洪虹,丘镜滢,赖悦云,等.干扰素α治疗Ph+慢性粒细胞白血病的细胞遗传学反应分析.中国实验血液学杂志,2003,11:269-273.
  • [4]牛家峰,张彩,张建华,等.IFN-α对宫颈癌细胞MHC-Ⅰ类链相关蛋白A表达的上调作用.细胞与分子免疫学杂志,2006,22:557-559,563.
  • [5]Zhang C,Zhang J,Wei H,et al.Imbalance of NKG2D and its inhibitory counterparts:how does tumor escape from innate immunity?Int Immunopharmacol,2005,5:1099-1111.
  • [6]Gonzalez S,Groh V,Spies T.Immunobiology of human NKG2D and its ligands.Curr Top Microbiol Immunol,2006,298:121-138.
  • [7]Pende D,Rivera P,Marcenaro S,et al.Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.Cancer Res,2002,62:6178-6186.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn